Académique Documents
Professionnel Documents
Culture Documents
Consultant Version
Introduction
A common challenge for primary care physicians is to determine the cause and to
find an effective treatment for patients with a swollen leg or both legs swollen. A
variety of clinical conditions, ranging from the benign to the potentially life-
threatening, is associated with the development of peripheral edema. These include
common conditions such as heart failure, liver cirrhosis, and nephrotic syndrome, as
well as local leg swelling due to deep vein thrombosis, use of certain medications,
or represent idiopathic edema. A systematic approach to the patient with swollen
lower extremities allows for prompt and cost-effective diagnosis and treatment.
Preparation3
All students should prepare questions 1–5 of the case at home by using the given
literature.
3
Preparation and assessment rules as used at TSMU – to be adapted to local requirements
152 Appendix
Assessment
Students: Active participation in the session, 1 point; absent or present but not
actively participating, 0 points
Peer teachers: Excellent preparation and leadership of the session, 2 points; suf-
ficient preparation and deficient leadership, 1 point; poor preparation and leader-
ship, 0 points.
Stage I
Question 1 5 min
Question 2 10 min
Question 3 10 min
Question 4 10 min
Question 5 5 min
Stage II
Handout 1
Question 6 10 min
Question 7 5 min
Question 8 10 min
Mini lecture: 10 min
Stage III
Handout 2
Question 9: 10 min
Question 10 10 min
Summary: 10 min
Appendix 153
Question 1 Based on the case presentation, what could be the cause of the
swelling of the legs, and are there any predisposing factors of
peripheral edema?
Question 2 Based on the history, what is the most likely problem of the patient?
DD HF LC NS VI Lymph Drugs PH IE
1. Leg edema> 72 h (during appr. 6 months)
2. Painless swelling
3. Bilateral
4. Improves at night
5. Shortness of breath on exertion
6. History of hypertension
7. Reduced urine volume
8. Consuming salty meals
HF heart failure, LC liver cirrhosis, NS nephrotic syndrome, VI venous insufficiency, PH pulmo-
nary hypertension, IE idiopathic edema
DD HF LC NS VI Lymph. Drugs PH IE
1. Leg edema> 72 h (appr. 6 months) + + + + + + + +
2. Painless swelling + + + + + + + +
3. Bilateral + + + + + + + +
4. Pitting + + + + − + + +
5. Improves at night + − − + − − − −
6. Shortness of breath on exertion + − − − − − − −
7. History of hypertension + − − − − − − −
8. Reduced urine volume + + + − − − − −
9. Consuming salty meals + + + − − − − −
HF heart failure, LC liver cirrhosis, NS nephrotic syndrome, VI venous insufficiency, PH pulmo-
nary hypertension, IE idiopathic edema
158 Appendix
dullness) and pleural cavities (dullness over lung bases) can be found in patients
with generalized edema. The key component of the differential diagnosis in
edematous patients is the evaluation of liver size by palpation and percussion.
Hepatomegaly may occur in right ventricular heart failure as well as in liver cir-
rhosis. Also the presence of hepatojugular reflux can be a useful test (applying
moderate pressure on the abdomen above the liver area) in patients with right-
sided heart failure.
Auscultation: The most specific auscultation finding in heart failure is appearance of
S3 which is indicative of high left ventricular dysfunction. In patients with dia-
stolic heart failure, S4 heart sound can be revealed. Systolic and/or diastolic mur-
murs can provide information on the cause of heart failure. Pulmonary congestion
is confirmed by audible rales and pleural effusion in severe cases.
Idiopathic edema can be diagnosed in young women without further testing if there
is no reason to suspect another etiology, based on history and physical examination.
Question 8 What diagnostic tests should you perform? Try to list tests that
could reveal a specific disease related to peripheral edema.
Mini lecture After Question 8 one of peer teachers gives a mini lecture on
specific diagnostic tests related to the differential diagnosis of
peripheral edema
• Bilirubin
• Albumin
• Lipids
Specific indications:
• Heart failure: ECG, echocardiography, plasma BNP level, chest X-ray
• Liver cirrhosis: ALT, AST, bilirubin, alkaline phosphatase, prothrombin time,
serum albumin, ultrasonography, liver biopsy
• Nephrotic syndrome: serum albumin, urinalysis, creatinine, serum lipids
• Lymphedema: abdominal/pelvic CT scan (to exclude malignancy)
• Chronic venous insufficiency (ambulatory venous pressure monitoring,
venous Duplex imaging, plethysmography)
Peer teachers should clarify the diagnostic route for each suspected pathological
condition emphasizing significance and specificity of each test in the context of
swollen legs.
In patients with swollen legs, CBC (complete blood analysis) data might indicate
certain conditions. Leukocytosis and redness and tenderness of legs are suspicious
for deep venous thrombosis, while anemia is more characteristic for chronic kidney
disease.
Hypoalbuminemia (normal range 3.5–5.5 g/dl or 35–55 g/l, or 50 %–60 % of
blood plasma proteins) usually appears in patients with nephrotic syndrome or liver
cirrhosis. Routine urinalysis and plasma level of lipids could help to distinguish
these two clinical conditions: heavy proteinuria, hypoalbuminemia, and hyperlipid-
emia (total cholesterol >10 mmol/l); elevated plasma level of creatinine (normal
range 0.6–1.3 mg/dl or 53–115 mcmol/l) confirms renal pathology (nephrotic syn-
drome). If these changes are accompanied by hyperglycemia, nephrotic syndrome
might be the result of diabetic nephropathy. Hyperbilirubinemia (normal range
0.2–1.2 mg/dL) and hypoalbuminemia most probably might be due to liver cirrho-
sis. Hypokalemia (normal range 3.5–5 mml/l) and hyponatremia (normal range
135–145 mmol/l) might be related to adverse effects of diuretics used in edematous
states and lead to exacerbation of causative conditions.
Despite the significance of aforementioned tests, additional, more specific diag-
nostic tools are needed to confirm the final diagnosis and identification of the only
condition that caused swollen legs. The following specific diagnostic tests are rec-
ommended for the suggested condition:
Heart failure; brain natriuretic peptide (BNP) is currently considered as the most
specific (about 90 %) biomarker for heart failure. Chest X-ray may reveal cardio-
megaly and pleural effusions; ECG may indicate the cause (myocardial infarction,
ventricular hypertrophy, etc.). Echocardiography is more specific and may indicate
the cause and confirm the presence of systolic or diastolic left ventricular
dysfunction.
Liver cirrhosis: The most specific invasive diagnostic tool for liver cirrhosis is
liver biopsy; however other noninvasive tests are also recommended: AST and ALT
enzymes (although they are not specific). Liver ultrasound + Duplex may show liver
162 Appendix
size, focal lesions, and ascites; MRI (magnetic resonance imaging) can quantify the
severity of cirrhosis and is considered a very useful test for estimating stage and
prognosis of liver cirrhosis.
Nephrotic syndrome: Renal biopsy is the most specific invasive diagnostic test;
however its use is limited. A less specific but widely used noninvasive diagnostic
test is renal ultrasound (detects size, shape, and location of kidneys).
Lymphedema: Diagnosis of leg lymphedema is usually obvious from physical
examination. Additional tests are indicated when secondary lymphedema is sus-
pected. CT and MRI can identify sites of lymphatic obstruction; radionuclide lym-
phoscintigraphy can identify lymphatic hypoplasia or sluggish flow.
Chronic venous insufficiency: Venous Duplex imaging is a well-established
rather specific method for the diagnosis of chronic venous insufficiency to assess its
etiology and severity. Ambulatory venous pressure monitoring is considered an
invasive gold standard in assessing the efficiency of the leg’s musculovenous pump.
The technique involves insertion of a needle into the pedal vein with connection to
a pressure transducer. A less specific test is plethysmography, a noninvasive diag-
nostic tool that quantifies the physiologic components of chronic venous disease
including chronic obstruction, valvular reflux, poor calf muscle pump function, and
venous hypertension.
Handout is shown on the screen and read out loud.
in some patients with diastolic dysfunction although their efficacy to prevent further
progression has not been proven yet.
Pharmacological treatment of heart failure, in great extent, depends on the type
of left ventricular dysfunction. In systolic dysfunction diuretics, ACE (angiotensin-
converting enzyme) inhibitors, ARBs (angiotensin receptor blockers), and beta-
blockers are recommended.
In diastolic heart failure, less drugs have been adequately studied. However, ACE
inhibitors, ARBs, and beta-blockers are generally used. The use of an implantable
cardioverter-defibrillator (ICD) or cardiac resynchronization therapy (CRT) is ben-
eficial for some patients.
Generally, patients with heart failure have a poor prognosis unless the cause is
correctable. Mortality rate in 1 year after the first hospitalization for HF is about
30 %. In chronic HF, mortality depends on severity of symptoms and ventricular
dysfunction and can range from 10 % to 40 % a year. Specific factors that suggest a
poor prognosis include hypotension, low EF, presence of CAD, troponin release,
elevation of BUN, reduced GFR, hyponatremia, and poor exercise capacity.
Arterial hypertension is considered to be the most important modifiable condi-
tion in the prevention or delay of progression of heart failure. In our case the
patient should be treated for arterial hypertension as a primary cause of heart
failure with antihypertensive drugs and diuretics (considering that he has diastolic
failure, the drug of choice should be a combination of a calcium channel blocker
with hydrochlorothiazide and additional ACE-I if needed). The patient should
restrict salt intake, since consuming excessive amount of sodium has been consid-
ered as one of the main triggers of the development of arterial hypertension and
progression of congestive heart failure as well. At this initial stage of heart failure,
the prognosis is good, and in case of patient’s compliance, signs of heart failure
might completely reverse. If the patient is not compliant and would not follow
recommended treatment, heart failure will progress, and his condition will worsen
up to the development of bilateral heart failure and generalized edema with a
rather poor prognosis.
Question 11 One of the students from the group summarizes the whole case
chronologically in a few minutes.